“We simply have no choice. We have to massively scale up bioenergy, and do it fast”, said Paolo Frankl, Head of the Renewable Energy Division at the International Energy Agency (IEA). “Sustainable bioenergy is an indispensable component of the necessary portfolio of low-carbon technologies in ALL climate-change mitigation scenarios”, said Frankl, based on the findings of a key upcoming report on the matter. “And there is a major, major gap between what we need and what is happening today in terms of the speed of deployment and the scale of investments in bioenergy”. The declarations were made as part of the Biofuture Summit, the first major conference of the Biofuture Platform, a coalition of twenty country governments, industry and the research community launched in November 2016 during UNFCCC COP23 in Marrakesh, aimed at the development of a modern, sustainable, low-carbon bioeconomy.
“The bioeconomy can and should be the path for the re-industrialization of Brazil, fostering much needed innovations and development of products and processes that will fast-track the establishment of the this new norm in a global scale”. To say this – in this exclusive interview with Il Bioeconomista – is Bernardo Silva, Executive President at Brazilian Industrial Biotechnology Association (in Portuguese ABBI – Associação Brasileira de Biotecnologia Industrial), a trade association that brings together companies and institutions developing and using microorganisms and its derivatives to deliver renewable products for industries and consumers worldwide. The founding members of ABBI are Amyris, BASF, BioChemtex, BP, Centro de Tecnologia Canavieira, Dow, DSM, DuPont, GranBio, Novozymes, Raízen and Rhodia. With Silva we talk about Brazilian bioeconomy and the country’s national strategy to support the field. “The ambition to establish a vibrant bioeconomy in Brazil, which values our comparative advantages and is able to realize the opportunities arising from this new model of development, entails a joint effort between government, business and civil society to discuss, define and practice a plan that ensures the alignment of policies in place and long-term strategies, paving the way for Brazil fulfill its role as a leader a global bio-based economy.”
Interview by Mario Bonaccorso
Australian headquartered Cardia Bioplastics announced that it is setting up its own film and bag manufacturing plant in São Paulo, Brazil. New purpose-built facilities have been leased and production commencement is scheduled for September 2014. The production machinery costing A$750,000 is funded using vendor finance over a twelve months period. The new factory is expected to deliver a production capacity of 500 million retail carry bags per year. This capacity is over four times greater than that of the current Cardia Bioplastics manufacturing plant in Nanjing, China.
Tetra Pak, the world leader in food processing and packaging solutions, headquartered in Sweden, announced that all of the packages it produces in Brazil are now using bio-based low-density polyethylene (LDPE). Combined with paperboard, the use of bio-based LDPE made from sugar cane increases the content of materials from renewable sources to as much as 82% in a Tetra Brik Aseptic 1000ml Base package, the world’s best selling carton package range for beverages.
The bio-based revolution extends to the carton packaging industry. In a first for this field, Tetra Pak, the Swedish multinational giant with net sales in 2012 of 11.15 billion euros, plans to sign an agreement with Braskem, the largest thermoplastic resins producer in the Americas, for the supply of low-density polyethylene (LDPE) made from sugar cane to its packaging material factories in Brazil.